# Monte Rosa Therapeutics, Inc.: Form 8-K, filed Sep 15, 2025

- Company: [Monte Rosa Therapeutics, Inc.](/companies/glue.md) (CIK 1826457)
- Form: 8-K
- Filed: 2025-09-15
- Accepted by EDGAR: Sep 15, 2025, 07:01 ET
- Period: 2025-09-15
- Accession: 0001193125-25-202760
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1826457/000119312525202760/glue-20250915.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826457/000119312525202760/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826457/000119312525202760/glue-20250915.htm

Filed Sep 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-202760. Last ingested by Listed: Nov 5, 2026, 11:59 ET. No prices; not investment advice.
